Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 20, 2025
Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [<sup>89</sup>Zr]ZrCl<sub>4</sub>
Serge K Lyashchenko, Tullio V Esposito, Tuan Tran, et al.
Nature Communications
|
February 5, 2016
ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function
Aarti Sharma, Alexander K Lyashchenko, Lei Lu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using <sup>89</sup>Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A Ulaner, Serge K Lyashchenko, Christopher Riedl, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2020
Comparison of <sup>68</sup>Ga-DOTA-JR11 PET/CT with dosimetric <sup>177</sup>Lu-satoreotide tetraxetan (<sup>177</sup>Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
Simone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.
Nuclear Medicine and Biology
|
May 26, 2019
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals
Sai Kiran Sharma, Serge K Lyashchenko, Hijin A Park, et al.
Infection and Immunity
|
August 14, 2001
Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis
S Johnson, P Brusasca, K Lyashchenko, et al.
EJNMMI Research
|
March 7, 2018
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
Jorge A Carrasquillo, Joseph A O'Donoghue, Volkan Beylergil, et al.
Radiology
|
April 8, 2020
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging
Gary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
Randy Yeh, Fresia Pareja, Parnian Shobeiri, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 20, 2025
Radiolabeling of CHX-A″-DTPA-Antibody Conjugates with [<sup>89</sup>Zr]ZrCl<sub>4</sub>
Serge K Lyashchenko, Tullio V Esposito, Tuan Tran, et al.
Nature Communications
|
February 5, 2016
ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function
Aarti Sharma, Alexander K Lyashchenko, Lei Lu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 18, 2017
First-in-Human Human Epidermal Growth Factor Receptor 2-Targeted Imaging Using <sup>89</sup>Zr-Pertuzumab PET/CT: Dosimetry and Clinical Application in Patients with Breast Cancer
Gary A Ulaner, Serge K Lyashchenko, Christopher Riedl, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 8, 2020
Comparison of <sup>68</sup>Ga-DOTA-JR11 PET/CT with dosimetric <sup>177</sup>Lu-satoreotide tetraxetan (<sup>177</sup>Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
Simone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.
Nuclear Medicine and Biology
|
May 26, 2019
A rapid bead-based radioligand binding assay for the determination of target-binding fraction and quality control of radiopharmaceuticals
Sai Kiran Sharma, Serge K Lyashchenko, Hijin A Park, et al.
Infection and Immunity
|
August 14, 2001
Characterization of the secreted MPT53 antigen of Mycobacterium tuberculosis
S Johnson, P Brusasca, K Lyashchenko, et al.
EJNMMI Research
|
March 7, 2018
I-124 codrituzumab imaging and biodistribution in patients with hepatocellular carcinoma
Jorge A Carrasquillo, Joseph A O'Donoghue, Volkan Beylergil, et al.
Radiology
|
April 8, 2020
CD38-targeted Immuno-PET of Multiple Myeloma: From Xenograft Models to First-in-Human Imaging
Gary A Ulaner, Nicholas B Sobol, Joseph A O'Donoghue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2019
Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist <sup>177</sup>Lu-Satoreotide Tetraxetan
Diane Reidy-Lagunes, Neeta Pandit-Taskar, Joseph A O'Donoghue, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 9, 2025
Detection of HER2-Low Lesions Using HER2-Targeted PET Imaging in Patients with Metastatic Breast Cancer: A Paired HER2 PET and Tumor Biopsy Analysis
Randy Yeh, Fresia Pareja, Parnian Shobeiri, et al.
Page
of 8